Suchergebnisse
Roche Holding AG ADR
WKN: 891106 / Symbol: RHHBY / Name: Roche / Aktie / Pharmazeutika / Large Cap /
Roche Finance Europe B.v.
WKN: A3LEL7 / Name: Roche Finance Europe B.v. / Aktie / ? /
Roche Finance Europe B.v.
WKN: A3LEL8 / Name: Roche Finance Europe B.v. / Aktie / ? /
Roche Finance Europe B.v.
WKN: A3LRTS / Name: Roche Finance Europe B.v. / Aktie / ? /
Roche Finance Europe B.v.
WKN: A3LRTT / Name: Roche Finance Europe B.v. / Aktie / ? /
Roche Finance Europe B.v.
WKN: A3LX6K / Name: Roche Finance Europe B.v. / Aktie / ? /
Roche Finance Europe B.v.
WKN: A3LX6L / Name: Roche Finance Europe B.v. / Aktie / ? /
FDA Accepts Roche's Filing for Lunsumio VELO-Polivy in LBCL
Roche RHHBY announced that the FDA has accepted its supplemental biologics license application (sBLA) seeking approval of Lunsumio VELO (mosunetuzumab), as a subcutaneous formulation, in combination
Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease
Roche RHHBY announced that the FDA has accepted and granted priority review to its supplemental biologics license application (sBLA) seeking label expansion of Enspryng (satralizumab) for the
